NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 – Clinical Trial Optional) RFA-EY-25-002. NEI
Participants in this module will learn: ▪ Differentiating etiologies of dry eye – aqueous deficiency and evaporative dry e ye disease. ▪ Evaluation and management…
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Join your colleagues for this engaging Industry Expert Theater Symposium. Sign up to receive a reminder of this meeting in your
With this addition, Zeiss completes the Corneal Refractive Workflow, which already includes Visumax 800 and SMILE pro.
This case report discusses use of bedside manual repositioning of an anteriorly dislocated crystalline lens in a patient with Marfan syndrome.
The financing will go toward its ongoing phase 2b/3 and planned pivotal phase 3 clinical trial for AVD-104.
The application was refiled following a December 20, 2024, meeting between the US Food and Drug Administration and Astellas.
Bausch + Lomb announced two seperate deals to acquire early- and mid-stage therapeutic assets. First, B+L, through an affiliate, acq
A recent study reports that abnormal sleep patterns may be risk factors for or consequences of glaucoma.
Whitecap is currently developing 2 therapies for potential use in glaucoma and geographic atrophy.
